Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.


BACKGROUND Lymphocyte recovery after autologous stem cell transplantation (ASCT) has been shown to be associated with positive clinical outcome in non-Hodgkin's lymphoma (NHL). This study sought to identify variables that affect lymphocyte recovery and survival after ASCT. STUDY DESIGN AND METHODS A retrospective analysis of outcomes in 97 consecutive… (More)
DOI: 10.1111/j.1537-2995.2009.02202.x


10 Figures and Tables